Orphacol ruling a blow for European Commission, but brings some legal clarity

The EU's General Court has annulled a decision by the European Commission to deny approval of Orphacol, a cholic acid-containing orphan drug for rare liver diseases produced by the French firm Laboratoires CTRS1. Among other things this means that the product can now receive an EU marketing authorization (MA).